Loading…

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia

Background. The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)–infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally. Methods. We analyzed cohort data from the International Epidemiologic Databases to Evaluate AIDS and the...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2016-11, Vol.63 (9), p.1245-1253
Main Authors: Rohner, Eliane, Schmidlin, Kurt, Zwahlen, Marcel, Chakraborty, Rana, Clifford, Gary, Obel, Niels, Grabar, Sophie, Verbon, Annelies, Noguera-Julian, Antoni, Collins, Intira Jeannie, Rojo, Pablo, Brockmeyer, Norbert, Campbell, Maria, Chêne, Geneviève, Prozesky, Hans, Eley, Brian, Stefan, D Cristina, Davidson, Alan, Chimbetete, Cleophas, Sawry, Shobna, Davies, Mary-Ann, Kariminia, Azar, Vibol, Ung, Sohn, Annette, Egger, Matthias, Bohlius, Julia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)–infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally. Methods. We analyzed cohort data from the International Epidemiologic Databases to Evaluate AIDS and the Collaboration of Observational HIV Epidemiological Research in Europe. We included HIV-infected children aged
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciw519